Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 1Hypertension 1Dyspnea 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

relacorilant 3Nutrition Assessment 2ganirelix 1clevidipine 1cediranib 1benazepril 1aliskiren 1Vitamin D 1Therapeutics 1Surveys and Questionnaires 1Sulindac 1Resistance Training 1Ramipril 1Observation 1Methyltestosterone 1Methods 1Losartan 1Lisinopril 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Interviews as Topic 1Fatty Acids, Omega-3 1Enalapril 1Educational Status 1Desvenlafaxine Succinate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hypertension × Lisinopril × Clear all
NCT01234922 2018-08-28

Benazepril Hydrochloride, Lisinopril, Ramipril, or Losartan Potassium in Treating Hypertension in Patients With Solid Tumors

Wake Forest University Health Sciences

Phase 2 Terminated
6 enrolled 10 charts

Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon âš¡